IXICO Appoints Andy Richards as Chairman to Initiate Next Phase of Growth
IXICO is delighted to announce that on 2nd September, Dr. Andy Richards joined the board as Chairman. Dr Richards is an established bio-science entrepreneur who has been instrumental in the founding or growth of several successful and innovative Healthcare companies including Chiroscience, Arakis, Cambridge Biotechnology, Altacor and Vectura. He has a track record in transforming companies from science based start ups to commercial ventures that raise funds and achieve successful exits. He has wide experience of commercialisation partnerships, M&A transactions and of private and public market financings.
London, UK (PRWEB) September 22, 2009
Dr Richards will be joining the Board of IXICO to help steer it through its next phase of growth as it expands its Imaging CRO services business and prepares to launch a new series of technology products that will transform the way that medical images are managed throughout the healthcare sector. IXICO's technology products include Trial WireTM-free, which was launched in April as a tool for sharing de-identifying and organization of medical image data for research purposes, and Trial TrackerTM, being launched this month, our next-generation image management solution that enables trial sponsors to track and control their data. Both products will be demonstrated at MICCAI, London and WMIC, Montreal in September.
In addition to his role on IXICO's board, Dr Richards holds other non-executive director positions including Vectura group plc, Summit Corp plc, Altacor, Biowisdom, Babraham Bioscience Technology and Cancer Research Technology (the commercial arm of CR-UK). He is a director of the UK Bio-industry Association and was recently voted both Cambridge Evening News Businessman of the Year and one of the Top100 Living Contributors to Biotechnology.
Derek Hill, IXICO's CEO said "We are very excited that Andy has joined our board. His enthusiasm, energy and experience will be invaluable as we take our business forward and explore the many opportunities available to us to enhance the way imaging is used in clinical trials, and explore new avenues for our technology."
Andy Richards commented "IXICO is an exciting and entrepreneurial healthcare information technology (HCIT) business. The solid commercial platform it has built in CRO services along with its transformational new technologies provide real opportunities for growth. I have been impressed with what Derek and his team have achieved to date and I look forward to help make IXICO an international commercial success"
About IXICO
IXICO is dedicated to improving the field of medical imaging through superior service and enabling technologies that support basic imaging research, routine clinical imaging, and imaging-based clinical trials. In its capacity as a full-service Imaging CRO, the company's Trial Service Division provides comprehensive, technology-based solutions and novel imaging biomarkers for the pharmaceutical and biotech industries across all therapeutic areas and clinical trials phases; from expert acquisition design and imaging site management to image QC and proven analysis techniques, IXICO's workflow technology and imaging know-how is driven by highly qualified and experienced experts and is underpinned by our robust quality management system. The company's New Product Division provides software solutions for image data management: improved regulatory-compliant image workflows, more efficient project management, data re-use; aggregation of data from multiple studies, and easier sharing and communication of images. To learn more about IXICO's service and product offerings, please visit www. ixico. com.
IXICO, Trial Wire and Trial Tracker are trademarks owned by IXICO LTD.
###